Significant variables from the univariate analysis were entered into 3 binary multivariate logistic regression models (deep infiltrating endometriosis versus endometrioma only, deep infiltrating endometriosis versus adenomyosis only, and adenomyosis only versus endometrioma only)
They recommended that the FDA remove restrictions that prevent pharmacies from creating certain injectable peptides, including BPC-157, TB-500 and KPV
Every one of these mechanistic claims, however, rests on animal and in-vitro data there is no human mechanistic confirmation
BPC-157, a 15-amino acid peptide derived from human gastric juice, shows remarkable potential for accelerating rib injury recovery based on preclinical research
I am beyond proud of the team we've built at Revelation Pharma to meet this moment the right way
Legal Status in Australia In Australia, BPC-157/TB-500 blends are not approved for human therapeutic use